Scott Freeman Author
Subjects of specialization
Affiliation
Interleukin 25, Systemic lupus erythematous disease activity index, Systemic lupus erythematous, Lupus nephritis
Biomedical Professional Specializing in SARS-CoV-2, Oncology, Rare Diseases/Orphan Drugs
After obtaining his Ph.D. in Cancer Biology, Scott conducted a Postdoctoral Fellowship at the Moffitt Cancer Center and was subsequently accepted into the highly competitive FDA Commissioner’s Fellowship Program where he worked in the Office of Orphan Products Development (OOPD) and published a paper in Cell Stem Cell. During the Fellowship